Literature DB >> 14570766

Characterization of mouse small intestinal cytochrome P450 expression.

Qing-Yu Zhang1, Debbie Dunbar, Laurence S Kaminsky.   

Abstract

The expression of biotransformation enzymes in mouse small intestine is poorly characterized, which limits the utility of transgenic or knockout mouse models for first-pass drug metabolism studies. In response, we have systematically examined the composition and inducibility of cytochrome P450 (P450) protein and mRNA in mouse small intestinal epithelial cells (enterocytes). RNA-PCR was conducted to confirm the expression and identity of CYP1A1, 1B1, 2B10, 2B19, 2B20, 2C29, 2C38, 2C40, 2E1, 3A11, 3A13, 3A16, 3A25, and 3A44 in the enterocytes of untreated mice, but CYP1A2, 2A4/5, 2A12, 2C37, 2C39, and 2F2 were not detected. The inducibility of CYP2B, 2C, and 3A subfamily forms was determined by real-time quantitative RNA-PCR. All five CYP3A forms were induced, in a range from 1.7- to 4.5-fold, by dexamethasone (DEX). Phenobarbital (PB) induced CYP2B9, CYP2B10, and CYP2B20 mRNAs and suppressed CYP2B19 mRNA levels. PB also induced CYP2C29 and CYP2C40, but not CYP2C38 mRNA. At the protein level, CYP1A1, CYP1B1, CYP2B, CYP2C, CYP2E1, and CYP3A were detected in enterocytes from untreated mice by immunoblot analysis. CYP1A1 was inducible by beta-naphthoflavone (BNF), CYP2B and CYP2C by PB, and CYP3A by DEX. CYP2B, 2C, and 3A proteins were all expressed at high levels proximally, and decreased distally. The inducibility of CYP1A1 followed a similar pattern. Intestinal P450 expression was compared between C57BL/6 (B6) and 129/sv (129) mice, strains commonly used in the preparation of transgenic and knockout mouse models. There was no significant strain difference in constitutive levels or induction patterns for CYP2B, 2C, and 3A protein. However, CYP1A1 was induced to a high level by BNF in B6 mice, but was not induced in the 129 mice.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14570766     DOI: 10.1124/dmd.31.11.1346

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  32 in total

1.  Preliminary physiologically based pharmacokinetic models for benzo[a]pyrene and dibenzo[def,p]chrysene in rodents.

Authors:  Susan Ritger Crowell; Shantu G Amin; Kim A Anderson; Gowdahalli Krishnegowda; Arun K Sharma; Jolen J Soelberg; David E Williams; Richard A Corley
Journal:  Toxicol Appl Pharmacol       Date:  2011-09-29       Impact factor: 4.219

2.  Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse.

Authors:  Yi Zhu; Jaime D'Agostino; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2011-02-24       Impact factor: 3.922

3.  Characterization of CYP2B6 in a CYP2B6-humanized mouse model: inducibility in the liver by phenobarbital and dexamethasone and role in nicotine metabolism in vivo.

Authors:  Zhihua Liu; Lei Li; Hong Wu; Jing Hu; Jun Ma; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2014-11-19       Impact factor: 3.922

4.  Cyp2b-Knockdown Mice Poorly Metabolize Corn Oil and Are Age-Dependent Obese.

Authors:  Basma Damiri; William S Baldwin
Journal:  Lipids       Date:  2018-11-12       Impact factor: 1.880

5.  Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.

Authors:  Shigeyuki Uno; Nadine Dragin; Marian L Miller; Timothy P Dalton; Frank J Gonzalez; Daniel W Nebert
Journal:  Free Radic Biol Med       Date:  2007-11-12       Impact factor: 7.376

6.  Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice.

Authors:  Susan F Hudachek; Daniel L Gustafson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-25       Impact factor: 2.745

7.  An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine.

Authors:  Qing-Yu Zhang; Cheng Fang; Jin Zhang; Deborah Dunbar; Laurence Kaminsky; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

8.  Generation and characterization of a novel Cyp2a(4/5)bgs-null mouse model.

Authors:  Yuan Wei; Lei Li; Xin Zhou; Qing-Yu Zhang; Anwar Dunbar; Fang Liu; Kerri Kluetzman; Weizhu Yang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-10-16       Impact factor: 3.922

9.  Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans.

Authors:  Susan F Hudachek; Daniel L Gustafson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-12       Impact factor: 2.745

Review 10.  Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.

Authors:  Hui Huang; Mohamed Al-Shabrawey; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-12-30       Impact factor: 3.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.